Search images on Google Product Monograph
Active Ingredients:
- panitumumab, 100 MG/5 ML
DIN: 02308487
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Schedule: Prescription
Company: AMGEN CANADA INC
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01F - (ATC, WHO)
- L01FE - (ATC, WHO)
- L01FE02 - PANITUMUMAB (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 5ML